NCT01334307已完成1 期
Randomized Controlled Trial Of RePneu (LVRC) Endobronchial Coils For The Treatment Of Severe Emphysema With Hyperinflation (RESET Study)
适应症
试验速览
- 阶段
- 1 期
- 状态
- 已完成
- 入组人数
- 47
- 试验地点
- 3
- 主要终点
- St. George's Respiratory Questionnaire (SGRQ)
研究概览
简要总结
The objective of this study is to demonstrate the safety and performance of the PneumRx, Inc. Lung Volume Reduction Coil (LVRC) in a population of patients with emphysema. The PneumRx, Inc. LVRC is used as a less invasive alternative to lung volume reduction surgery.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 年龄范围
- 35 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Patient greater than or equal to 35 years of age
- •High resolution CT scan indicates unilateral or bilateral emphysema
- •High resolution CT scan indicates homogeneous or heterogeneous emphysema
- •Patient has post-bronchodilator FEV1 less than or equal to 45% predicted
- •Total Lung Capacity greater than 100% predicted
- •Patient has marked dyspnea scoring greater than or equal to 2 on mMRC scale of 0-4
- •Patient has stopped smoking for a minimum of 8 weeks prior to entering the study
- •Patient (and legal guardian if applicable) read, understood and signed the Informed Consent form
排除标准
- •Patient has a change in FEV1 greater than 20% post-bronchodilator
- •Patients DLCO less than 20% predicted
- •Patient has a history of recurrent clinically significant respiratory infection
- •Patient has uncontrolled pulmonary hypertension defined by right ventricular pressure greater than 50mm Hg and/or evidenced by echocardiogram
- •Patient has an inability to walk greater than 140 meters (150 yards) in 6 minutes
- •Patient has evidence of other disease that may compromise survival such as lung cancer, renal failure, etc
- •Patient is pregnant or lactating
- •Patient has an inability to tolerate bronchoscopy under heavy sedation or anesthesia
- •Patient has clinically significant bronchiectasis
- •Patient has giant bullae greater than 1/3 lung volume
- •Patient has had previous LVR surgery, lung transplant or lobectomy
- •Patient has been involved in other pulmonary drug studies with 30 days prior to this study
- •Patient is taking greater than 20 mg prednisone (or similar steroid) daily
- •Patient is on Plavix or has not been weaned off prior to procedure
- •Patient has other disease that would interfere with completion of study, follow up assessments or that would adversely affect outcomes
结局指标
主要结局
St. George's Respiratory Questionnaire (SGRQ)
时间窗: three month Follow-Up Visit
The primary efficacy endpoint will be the difference between treatment and control groups in the change in St. George's Respiratory Questionnaire (SGRQ) from Baseline (Pre-Treatment Visit) to the three month Follow-Up Visit.
次要结局
未报告次要终点
研究者
研究点 (3)
Loading locations...
相似试验
撤回
不适用
Lung Volume Reduction Coils for Emphysema in Alpha-1 Antitrypsin DeficiencyAlpha-1-Antitrypsin DeficiencyChronic Obstructive Lung DiseaseEmphysemaNCT02273349University Hospital, Saarland
已完成
不适用
Evaluation of the PneumRx Lung Volume Reduction Coil to Treat EmphysemaEmphysemaNCT01220908Boston Scientific Corporation36
已完成
不适用
Pulmonary Surgery and Protective Mechanical VentilationLung NeoplasmsNCT00805077Assistance Publique - Hôpitaux de Paris347
招募中
不适用
Use of Ex Vivo Lung Perfusion (EVLP) in Reconditioning Marginal Donor Lungs for TransplantationLung TransplantNCT02235610Centre hospitalier de l'Université de Montréal (CHUM)50
Unknown
不适用
The Study of Regional Lung Ventilation-perfusion by EITPulmonary VentilationPulmonary PerfusionNCT05105932Peking Union Medical College Hospital100